Biomedical entrepreneurship in U.S. regions
Entrepreneurial ecosystem researchers generally focus on the few dominant factors affecting entrepreneurship. Insufficient attention has been paid to the interdependencies among regional conditions within an entrepreneurial ecosystem. We focus on the collective effects of factors for regional biomed...
Gespeichert in:
| Veröffentlicht in: | The Journal of technology transfer 2024-04, Vol.49 (2), p.782-800 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 800 |
|---|---|
| container_issue | 2 |
| container_start_page | 782 |
| container_title | The Journal of technology transfer |
| container_volume | 49 |
| creator | Park, Sang-Min Vonortas, Nicholas S. |
| description | Entrepreneurial ecosystem researchers generally focus on the few dominant factors affecting entrepreneurship. Insufficient attention has been paid to the interdependencies among regional conditions within an entrepreneurial ecosystem. We focus on the collective effects of factors for regional biomedical entrepreneurship. We use the fuzzy-set qualitative comparative analysis (fsQCA) method to identify sets of regional conditions promoting biomedical entrepreneurship in all 381 U.S. metropolitan areas. The results indicate three configurations contributing to high levels of regional biomedical entrepreneurship: the first one combines public sector biomedical R&D, biomedical patents, and human capital, thus stressing science conditions and related human capital; the second combines public sector biomedical R&D, biomedical patents, clinical trials, and venture capital, thus placing more emphasis on the regional infrastructure sustaining entrepreneurial activity; the third combines private sector biomedical R&D, biomedical patents, human capital, per capita income, population density, and venture capital, thus emphasizing the private sector’s role on boosting regional biomedical entrepreneurship. There is no single recipe for a region to increase its level of biomedical entrepreneurship. |
| doi_str_mv | 10.1007/s10961-023-09996-8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3043576817</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3043576817</sourcerecordid><originalsourceid>FETCH-LOGICAL-c328t-6688763a2f627ce5e7ee9226a39f2ace4bf54e31e8d197ee7f4b311ad91711603</originalsourceid><addsrcrecordid>eNp9kM1LAzEQxYMoWKv_gKcFj5I6k2zzcdTiFxQ8aM8h3c7WLW12TbYH_3ujK9STpxmY33tveIxdIkwQQN8kBKuQg5AcrLWKmyM2AmMFtxbF8Z_9lJ2ltAGAEoQeseu7pt3Rqqn8tqDQR-oiBdrH9N50RROKxeR1UkRaN21I5-yk9ttEF79zzBYP92-zJz5_eXye3c55JYXpuVLGaCW9qJXQFU1JE1khlJe2Fr6icllPS5JIZoU233RdLiWiX1nUiArkmF0Nvl1sP_aUerdp9zHkSCehlFOtDOpMiYGqYptSpNp1sdn5-OkQ3HcpbijF5VLcTynOZFExiKhqQ5MOEpup_ATYjMgBSfkY1hQP6f8YfwGTh20z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3043576817</pqid></control><display><type>article</type><title>Biomedical entrepreneurship in U.S. regions</title><source>PAIS Index</source><source>Springer Nature - Complete Springer Journals</source><creator>Park, Sang-Min ; Vonortas, Nicholas S.</creator><creatorcontrib>Park, Sang-Min ; Vonortas, Nicholas S.</creatorcontrib><description>Entrepreneurial ecosystem researchers generally focus on the few dominant factors affecting entrepreneurship. Insufficient attention has been paid to the interdependencies among regional conditions within an entrepreneurial ecosystem. We focus on the collective effects of factors for regional biomedical entrepreneurship. We use the fuzzy-set qualitative comparative analysis (fsQCA) method to identify sets of regional conditions promoting biomedical entrepreneurship in all 381 U.S. metropolitan areas. The results indicate three configurations contributing to high levels of regional biomedical entrepreneurship: the first one combines public sector biomedical R&D, biomedical patents, and human capital, thus stressing science conditions and related human capital; the second combines public sector biomedical R&D, biomedical patents, clinical trials, and venture capital, thus placing more emphasis on the regional infrastructure sustaining entrepreneurial activity; the third combines private sector biomedical R&D, biomedical patents, human capital, per capita income, population density, and venture capital, thus emphasizing the private sector’s role on boosting regional biomedical entrepreneurship. There is no single recipe for a region to increase its level of biomedical entrepreneurship.</description><identifier>ISSN: 0892-9912</identifier><identifier>EISSN: 0892-9912</identifier><identifier>EISSN: 1573-7047</identifier><identifier>DOI: 10.1007/s10961-023-09996-8</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Biomedical research ; Biotechnology industry ; Business and Management ; Clinical trials ; Commercial Law ; Comparative analysis ; Economic Growth ; Entrepreneurs ; Entrepreneurship ; Fuzzy sets ; Human capital ; Identification methods ; Industrial Organization ; Innovation/Technology Management ; Management ; Metropolitan areas ; Population density ; Private sector ; Public sector ; Qualitative analysis ; Qualitative research ; R&D ; Regions ; Research & development ; Venture capital</subject><ispartof>The Journal of technology transfer, 2024-04, Vol.49 (2), p.782-800</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c328t-6688763a2f627ce5e7ee9226a39f2ace4bf54e31e8d197ee7f4b311ad91711603</cites><orcidid>0000-0002-1290-3544 ; 0000-0002-6745-4926</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10961-023-09996-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10961-023-09996-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27847,27905,27906,41469,42538,51300</link.rule.ids></links><search><creatorcontrib>Park, Sang-Min</creatorcontrib><creatorcontrib>Vonortas, Nicholas S.</creatorcontrib><title>Biomedical entrepreneurship in U.S. regions</title><title>The Journal of technology transfer</title><addtitle>J Technol Transf</addtitle><description>Entrepreneurial ecosystem researchers generally focus on the few dominant factors affecting entrepreneurship. Insufficient attention has been paid to the interdependencies among regional conditions within an entrepreneurial ecosystem. We focus on the collective effects of factors for regional biomedical entrepreneurship. We use the fuzzy-set qualitative comparative analysis (fsQCA) method to identify sets of regional conditions promoting biomedical entrepreneurship in all 381 U.S. metropolitan areas. The results indicate three configurations contributing to high levels of regional biomedical entrepreneurship: the first one combines public sector biomedical R&D, biomedical patents, and human capital, thus stressing science conditions and related human capital; the second combines public sector biomedical R&D, biomedical patents, clinical trials, and venture capital, thus placing more emphasis on the regional infrastructure sustaining entrepreneurial activity; the third combines private sector biomedical R&D, biomedical patents, human capital, per capita income, population density, and venture capital, thus emphasizing the private sector’s role on boosting regional biomedical entrepreneurship. There is no single recipe for a region to increase its level of biomedical entrepreneurship.</description><subject>Biomedical research</subject><subject>Biotechnology industry</subject><subject>Business and Management</subject><subject>Clinical trials</subject><subject>Commercial Law</subject><subject>Comparative analysis</subject><subject>Economic Growth</subject><subject>Entrepreneurs</subject><subject>Entrepreneurship</subject><subject>Fuzzy sets</subject><subject>Human capital</subject><subject>Identification methods</subject><subject>Industrial Organization</subject><subject>Innovation/Technology Management</subject><subject>Management</subject><subject>Metropolitan areas</subject><subject>Population density</subject><subject>Private sector</subject><subject>Public sector</subject><subject>Qualitative analysis</subject><subject>Qualitative research</subject><subject>R&D</subject><subject>Regions</subject><subject>Research & development</subject><subject>Venture capital</subject><issn>0892-9912</issn><issn>0892-9912</issn><issn>1573-7047</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>7TQ</sourceid><recordid>eNp9kM1LAzEQxYMoWKv_gKcFj5I6k2zzcdTiFxQ8aM8h3c7WLW12TbYH_3ujK9STpxmY33tveIxdIkwQQN8kBKuQg5AcrLWKmyM2AmMFtxbF8Z_9lJ2ltAGAEoQeseu7pt3Rqqn8tqDQR-oiBdrH9N50RROKxeR1UkRaN21I5-yk9ttEF79zzBYP92-zJz5_eXye3c55JYXpuVLGaCW9qJXQFU1JE1khlJe2Fr6icllPS5JIZoU233RdLiWiX1nUiArkmF0Nvl1sP_aUerdp9zHkSCehlFOtDOpMiYGqYptSpNp1sdn5-OkQ3HcpbijF5VLcTynOZFExiKhqQ5MOEpup_ATYjMgBSfkY1hQP6f8YfwGTh20z</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Park, Sang-Min</creator><creator>Vonortas, Nicholas S.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>OQ6</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TA</scope><scope>7TB</scope><scope>7TQ</scope><scope>8FD</scope><scope>DHY</scope><scope>DON</scope><scope>FR3</scope><scope>JG9</scope><orcidid>https://orcid.org/0000-0002-1290-3544</orcidid><orcidid>https://orcid.org/0000-0002-6745-4926</orcidid></search><sort><creationdate>20240401</creationdate><title>Biomedical entrepreneurship in U.S. regions</title><author>Park, Sang-Min ; Vonortas, Nicholas S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c328t-6688763a2f627ce5e7ee9226a39f2ace4bf54e31e8d197ee7f4b311ad91711603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomedical research</topic><topic>Biotechnology industry</topic><topic>Business and Management</topic><topic>Clinical trials</topic><topic>Commercial Law</topic><topic>Comparative analysis</topic><topic>Economic Growth</topic><topic>Entrepreneurs</topic><topic>Entrepreneurship</topic><topic>Fuzzy sets</topic><topic>Human capital</topic><topic>Identification methods</topic><topic>Industrial Organization</topic><topic>Innovation/Technology Management</topic><topic>Management</topic><topic>Metropolitan areas</topic><topic>Population density</topic><topic>Private sector</topic><topic>Public sector</topic><topic>Qualitative analysis</topic><topic>Qualitative research</topic><topic>R&D</topic><topic>Regions</topic><topic>Research & development</topic><topic>Venture capital</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Park, Sang-Min</creatorcontrib><creatorcontrib>Vonortas, Nicholas S.</creatorcontrib><collection>ECONIS</collection><collection>CrossRef</collection><collection>Materials Business File</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>PAIS Index</collection><collection>Technology Research Database</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>Engineering Research Database</collection><collection>Materials Research Database</collection><jtitle>The Journal of technology transfer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Park, Sang-Min</au><au>Vonortas, Nicholas S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biomedical entrepreneurship in U.S. regions</atitle><jtitle>The Journal of technology transfer</jtitle><stitle>J Technol Transf</stitle><date>2024-04-01</date><risdate>2024</risdate><volume>49</volume><issue>2</issue><spage>782</spage><epage>800</epage><pages>782-800</pages><issn>0892-9912</issn><eissn>0892-9912</eissn><eissn>1573-7047</eissn><abstract>Entrepreneurial ecosystem researchers generally focus on the few dominant factors affecting entrepreneurship. Insufficient attention has been paid to the interdependencies among regional conditions within an entrepreneurial ecosystem. We focus on the collective effects of factors for regional biomedical entrepreneurship. We use the fuzzy-set qualitative comparative analysis (fsQCA) method to identify sets of regional conditions promoting biomedical entrepreneurship in all 381 U.S. metropolitan areas. The results indicate three configurations contributing to high levels of regional biomedical entrepreneurship: the first one combines public sector biomedical R&D, biomedical patents, and human capital, thus stressing science conditions and related human capital; the second combines public sector biomedical R&D, biomedical patents, clinical trials, and venture capital, thus placing more emphasis on the regional infrastructure sustaining entrepreneurial activity; the third combines private sector biomedical R&D, biomedical patents, human capital, per capita income, population density, and venture capital, thus emphasizing the private sector’s role on boosting regional biomedical entrepreneurship. There is no single recipe for a region to increase its level of biomedical entrepreneurship.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s10961-023-09996-8</doi><tpages>19</tpages><orcidid>https://orcid.org/0000-0002-1290-3544</orcidid><orcidid>https://orcid.org/0000-0002-6745-4926</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0892-9912 |
| ispartof | The Journal of technology transfer, 2024-04, Vol.49 (2), p.782-800 |
| issn | 0892-9912 0892-9912 1573-7047 |
| language | eng |
| recordid | cdi_proquest_journals_3043576817 |
| source | PAIS Index; Springer Nature - Complete Springer Journals |
| subjects | Biomedical research Biotechnology industry Business and Management Clinical trials Commercial Law Comparative analysis Economic Growth Entrepreneurs Entrepreneurship Fuzzy sets Human capital Identification methods Industrial Organization Innovation/Technology Management Management Metropolitan areas Population density Private sector Public sector Qualitative analysis Qualitative research R&D Regions Research & development Venture capital |
| title | Biomedical entrepreneurship in U.S. regions |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T14%3A34%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biomedical%20entrepreneurship%20in%20U.S.%20regions&rft.jtitle=The%20Journal%20of%20technology%20transfer&rft.au=Park,%20Sang-Min&rft.date=2024-04-01&rft.volume=49&rft.issue=2&rft.spage=782&rft.epage=800&rft.pages=782-800&rft.issn=0892-9912&rft.eissn=0892-9912&rft_id=info:doi/10.1007/s10961-023-09996-8&rft_dat=%3Cproquest_cross%3E3043576817%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3043576817&rft_id=info:pmid/&rfr_iscdi=true |